Neil L. Berkley
Directeur/Membre du Conseil chez Navigen, Inc.
Profil
Neil L.
Berkley is the founder of MPEX Pharmaceuticals, Inc. (founded in 2001) and Vaxiion Therapeutics, Inc. (founded in 2000).
He is currently a Director at Navigen, Inc. Mr. Berkley's former jobs include Vice President & Head-Business Development at Halozyme Therapeutics, Inc., Head-Business Development at Cadence Pharmaceuticals, Inc., and Chief Business Officer at AbCellera Biologics, Inc. (2021-2022).
He was also an Independent Non-Executive Director at ProLung, Inc. in 2018.
Mr. Berkley's education includes a graduate degree and an MBA from San Diego State University, and an undergraduate degree from the University of California San Diego.
Postes actifs de Neil L. Berkley
| Sociétés | Poste | Début |
|---|---|---|
Navigen, Inc.
 Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Directeur/Membre du Conseil | - |
Anciens postes connus de Neil L. Berkley
| Sociétés | Poste | Fin |
|---|---|---|
| ABCELLERA BIOLOGICS INC. | Corporate Officer/Principal | 29/06/2022 |
| PROLUNG, INC. | Directeur/Membre du Conseil | 27/06/2018 |
| Cadence Pharmaceuticals , Inc. | Corporate Officer/Principal | - |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | - |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Fondateur | - |
Formation de Neil L. Berkley
| San Diego State University | Graduate Degree |
| University of California San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| ABCELLERA BIOLOGICS INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
ProLung, Inc.
 ProLung, Inc. Medical SpecialtiesHealth Technology ProLung, Inc. is a medical technology company, which specializes in predictive analytics technology, early stage lung cancer risk testing. It develops, tests and commercializes solutions which are designed to accelerate the time to diagnosis and expand the therapeutic window for lung cancer patients. Its product under the name of ProLung Test was developed to assess the risk of malignancy in lung nodules found in the chest by a Computed Tomography scan. The company was founded by Steven C. Eror on November 19, 2004 and is headquartered in Salt Lake City, UT. | Health Technology |
MPEX Pharmaceuticals, Inc.
MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Commercial Services |
Vaxiion Therapeutics, Inc.
 Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Health Technology |
Navigen, Inc.
Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Health Technology |
| Cadence Pharmaceuticals , Inc. |
